<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04117997</url>
  </required_header>
  <id_info>
    <org_study_id>Fugl-Meyer Italian 2</org_study_id>
    <nct_id>NCT04117997</nct_id>
  </id_info>
  <brief_title>Validation Fugl-Meyer in Italian Language (FMI)</brief_title>
  <official_title>Validation of the Evaluation Scale Fugl-Meyer in Italian Language</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Don Carlo Gnocchi Onlus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione Don Carlo Gnocchi Onlus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to perform a cultural validation of the Italian translation of the
      Fugl-Meyer Assessment scale for the upper and the lower limb on a group of post-stroke
      patients admitted to the neurological department at The Don Carlo Foundation.

      The purpose is to validate the Italian translation of the Fugl-Meyer Assessment scale in
      order to allow immediate clinical use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Fugl-Meyer Assessment (FMA) is one of the most used and recommended assessment scales of
      sensorimotor function in stroke. It was introduced for the first time by Axl Fugl-Meyer and
      collaborators and originally published in both English and Swedish, representing the first
      quantitative assessment tool for the hemiplegic patient.

      The FMA is a valid, reliable, responsive and most widely used standardized clinical scale for
      the evaluation of the degree of sensory and motor impairment of the hemiplegic patient, and
      to date is considered one of the most used tools worldwide. Extensive research has shown that
      FMA is easy to use and does not require special equipment, making it particularly suitable
      for different types of clinical setting around the world.

      There are many currently translation and cultural validation studies of the FMA in several
      languages (Danish, Norwegian, Spanish, French), but an official version validated in Italian
      is no available to date.

      This study aims to perform and develop a transcultural validation of the FMA for the upper
      and the lower limbs in Italian, following a methodological approach, already validated, for
      the process of translation and cultural adaptation, including formal involvement of the
      University of Gothenburg, which holds the rights on the original scale.

      The translated version in Italian is tested by 3 physiotherapists admitted to the
      neurological department at The Don Carlo Foundation, in order to identify lingual and
      conceptual inconsistencies that could influence the score, the understanding, the
      interpretation and the cultural equivalence of the scale.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Assessment</measure>
    <time_frame>1 day</time_frame>
    <description>sensory and motor recovery assessment after stroke, total score from 0 to 64, subscore upper limb 36, lower limb 28. Higher scores represent better outcomes</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Validation Fugl-Meyer Scale in Italian</condition>
  <eligibility>
    <study_pop>
      <textblock>
        60 individuals with stroke consecutively admitted to the neurological department at The Don
        Carlo Foundation, 4-9 days post-stroke. The patients will be aged between 18-90 years old.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: 60 individuals with first-ever stroke will be enrolled. Eligible
        subjects will be in-patients with an acute event occurred no later than 15 days from
        admission at the &quot;neurological department &quot; at the Don Carlo Gnocchi Foundation.

        Exclusion Criteria:

        Visual and/ or hearing deficits, amputation of the upper or lower limb, cerebellar stroke;
        previous strokes (relapse), cognitive decline (MMSE&lt;21).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francesca Cecchi, MD</last_name>
    <phone>05573931</phone>
    <email>fcecchi@dongnocchi.it</email>
  </overall_contact>
  <results_reference>
    <citation>Fugl-Meyer AR, Jääskö L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13-31.</citation>
    <PMID>1135616</PMID>
  </results_reference>
  <results_reference>
    <citation>Barbosa NE, Forero SM, Galeano CP, Hernández ED, Landinez NS, Sunnerhagen KS, Alt Murphy M. Translation and cultural validation of clinical observational scales - the Fugl-Meyer assessment for post stroke sensorimotor function in Colombian Spanish. Disabil Rehabil. 2019 Sep;41(19):2317-2323. doi: 10.1080/09638288.2018.1464604. Epub 2018 Apr 24.</citation>
    <PMID>29688080</PMID>
  </results_reference>
  <results_reference>
    <citation>Lundquist CB, Maribo T. The Fugl-Meyer assessment of the upper extremity: reliability, responsiveness and validity of the Danish version. Disabil Rehabil. 2017 May;39(9):934-939. doi: 10.3109/09638288.2016.1163422. Epub 2016 Apr 10.</citation>
    <PMID>27062881</PMID>
  </results_reference>
  <results_reference>
    <citation>Santisteban L, Térémetz M, Bleton JP, Baron JC, Maier MA, Lindberg PG. Upper Limb Outcome Measures Used in Stroke Rehabilitation Studies: A Systematic Literature Review. PLoS One. 2016 May 6;11(5):e0154792. doi: 10.1371/journal.pone.0154792. eCollection 2016. Review.</citation>
    <PMID>27152853</PMID>
  </results_reference>
  <results_reference>
    <citation>Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005 Mar-Apr;8(2):94-104.</citation>
    <PMID>15804318</PMID>
  </results_reference>
  <results_reference>
    <citation>Sousa VD, Rojjanasrirat W. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: a clear and user-friendly guideline. J Eval Clin Pract. 2011 Apr;17(2):268-74. doi: 10.1111/j.1365-2753.2010.01434.x. Epub 2010 Sep 28.</citation>
    <PMID>20874835</PMID>
  </results_reference>
  <results_reference>
    <citation>Schuster C, Hahn S, Ettlin T. Objectively-assessed outcome measures: a translation and cross-cultural adaptation procedure applied to the Chedoke McMaster Arm and Hand Activity Inventory (CAHAI). BMC Med Res Methodol. 2010 Nov 29;10:106. doi: 10.1186/1471-2288-10-106.</citation>
    <PMID>21114807</PMID>
  </results_reference>
  <results_reference>
    <citation>Michaelsen SM, Rocha AS, Knabben RJ, Rodrigues LP, Fernandes CG. Translation, adaptation and inter-rater reliability of the administration manual for the Fugl-Meyer assessment. Rev Bras Fisioter. 2011 Jan-Feb;15(1):80-8.</citation>
    <PMID>21519719</PMID>
  </results_reference>
  <results_reference>
    <citation>See J, Dodakian L, Chou C, Chan V, McKenzie A, Reinkensmeyer DJ, Cramer SC. A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013 Oct;27(8):732-41. doi: 10.1177/1545968313491000. Epub 2013 Jun 17.</citation>
    <PMID>23774125</PMID>
  </results_reference>
  <results_reference>
    <citation>Sánchez R, Echeverry J. [Validating scales used for measuring factors in medicine]. Rev Salud Publica (Bogota). 2004 Sep-Dec;6(3):302-18. Spanish.</citation>
    <PMID>15656069</PMID>
  </results_reference>
  <results_reference>
    <citation>Svensson E. Different ranking approaches defining association and agreement measures of paired ordinal data. Stat Med. 2012 Nov 20;31(26):3104-17. doi: 10.1002/sim.5382. Epub 2012 Jun 19.</citation>
    <PMID>22714677</PMID>
  </results_reference>
  <results_reference>
    <citation>Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968 Oct;70(4):213-20.</citation>
    <PMID>19673146</PMID>
  </results_reference>
  <results_reference>
    <citation>Kazdin AE. Artifact, bias, and complexity of assessment: the ABCs of reliability. J Appl Behav Anal. 1977 Spring;10(1):141-50.</citation>
    <PMID>16795543</PMID>
  </results_reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 4, 2019</study_first_submitted>
  <study_first_submitted_qc>October 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2019</study_first_posted>
  <last_update_submitted>November 20, 2019</last_update_submitted>
  <last_update_submitted_qc>November 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione Don Carlo Gnocchi Onlus</investigator_affiliation>
    <investigator_full_name>Francesca Cecchi</investigator_full_name>
    <investigator_title>Dr. Francesca Cecchi</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We haven't plan to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

